Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma

Overview of attention for article published in Cancer Cell, April 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
twitter: 31 tweeters

facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 115 Dimensions

Readers on

mendeley: 310 Mendeley
citeulike: 1 CiteULike

Summary News Blogs Twitter Facebook Research highlights Dimensions citations

So far, Dimensions has found 115 publications that cite this research output.

115

The most recent citing publications are shown below. View all 115 publications that cite this research output on Dimensions.

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed GlioblastomaGBM: Tumor Sunitinib Concentrations and Phosphoproteomics

Article in Clinical Cancer Research (February 2022)

Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma

Article in Neuro-Oncology (December 2021)

Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures

Article in Genome Medicine (December 2021)